CONTRIBUTION OF MERCAPTOPURINE DOSE INTENSIFICATION TO IMPROVED OUTCOME IN PATIENTS WITH LOWER-RISK ALL

被引:5
作者
ABROMOWITCH, M
FAIRCLOUGH, D
机构
关键词
D O I
10.1200/JCO.1990.8.8.1442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1442 / 1442
页数:1
相关论文
共 4 条
[1]   HIGH-DOSE METHOTREXATE IMPROVES CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - ST-JUDE TOTAL THERAPY STUDY [J].
ABROMOWITCH, M ;
OCHS, J ;
PUI, CH ;
KALWINSKY, D ;
RIVERA, GK ;
FAIRCLOUGH, D ;
LOOK, AT ;
HUSTU, HO ;
MURPHY, SB ;
EVANS, WE ;
DAHL, GV ;
BOWMAN, WP .
MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05) :297-303
[2]  
ABROMOWITCH M, 1989, BLOOD, V71, P866
[3]   INTERMEDIATE-DOSE INTRAVENOUS METHOTREXATE AND MERCAPTOPURINE THERAPY FOR NON-T, NON-B ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
CAMITTA, B ;
LEVENTHAL, B ;
LAUER, S ;
SHUSTER, JJ ;
ADAIR, S ;
CASPER, J ;
CIVIN, C ;
GRAHAM, M ;
MAHONEY, D ;
MUNOZ, L ;
KIEFER, G ;
KAMEN, B .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1539-1544
[4]  
Efron B., 1986, STAT SCI, P54, DOI DOI 10.1214/SS/1177013815